These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10434816)

  • 1. Magnitude and time course of impaired primary haemostasis after stopping chronic low and medium dose aspirin in healthy volunteers.
    Sonksen JR; Kong KL; Holder R
    Br J Anaesth; 1999 Mar; 82(3):360-5. PubMed ID: 10434816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures.
    Komatsu T; Tamai Y; Takami H; Yamagata K; Fukuda S; Munakata A
    J Gastroenterol; 2005 Jul; 40(7):698-707. PubMed ID: 16082586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of increased bleeding tendency after cessation of aspirin therapy.
    Cahill RA; McGreal GT; Crowe BH; Ryan DA; Manning BJ; Cahill MR; Redmond HP
    J Am Coll Surg; 2005 Apr; 200(4):564-73; quiz A59-61. PubMed ID: 15804471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of aspirin on platelet count and volume in humans.
    Erhart S; Beer JH; Reinhart WH
    Acta Haematol; 1999; 101(3):140-4. PubMed ID: 10352333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exploring the effect of aspirin on primary hemostasis through bleeding time. Study of 16 volunteers].
    Gargouri J; Mnif H; Sellami S; Rekik H
    Tunis Med; 2004 Feb; 82(2):219-22. PubMed ID: 15185599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects of aspirin on bleeding time measured using the Simplate method and closure time measured using the PFA-100, in healthy volunteers.
    Marshall PW; Williams AJ; Dixon RM; Growcott JW; Warburton S; Armstrong J; Moores J
    Br J Clin Pharmacol; 1997 Aug; 44(2):151-5. PubMed ID: 9278200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the effects of ketorolac and aspirin on hemostasis in the rabbit].
    Samama CM; Daghfous M; Delaporte-Cerceau S; Nafziger J; Drouet L; Riou B; Coriat P
    Ann Fr Anesth Reanim; 1995; 14(5):393-8. PubMed ID: 8572405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Clot Signature Analyzer as a hemostasis test in healthy volunteers exposed to low doses of aspirin.
    Igawa T; Kornhauser R; Cilla DD; King JO; Kambayashi J
    Clin Appl Thromb Hemost; 1999 Apr; 5(2):117-21. PubMed ID: 10725992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial comparing point-of-care platelet function assays and bleeding time in healthy subjects treated with aspirin or clopidogrel.
    Chen F; Maridakis V; O'neill EA; Beals C; Radziszewski W; de Lepeleire I; Van Dyck K; Depré M; Bolognese JA; de Hoon J; Jacquemin M
    Platelets; 2012; 23(4):249-58. PubMed ID: 21919555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin Resistance in Different Doses by Bleeding Time and Urinary 11-dehydro-thromboxane B2.
    Maleki A; Cheraghi M; Kerman SRJ; Montazeri M; Rashidi N; Ghanavati R; Foroughi S; Alyari F; Ahmadvand H
    Indian J Physiol Pharmacol; 2016; 60(1):30-7. PubMed ID: 29953191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled study on the influence of acetaminophen, diclofenac, or naproxen on aspirin-induced inhibition of platelet aggregation.
    Galliard-Grigioni KS; Reinhart WH
    Eur J Pharmacol; 2009 May; 609(1-3):96-9. PubMed ID: 19272375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of low-dose desmopressin in improving hypothermia-induced impairment of primary haemostasis under influence of aspirin - a randomized controlled trial.
    Tsui PY; Cheung CW; Lee Y; Leung SW; Ng KF
    BMC Anesthesiol; 2015 May; 15():80. PubMed ID: 26017715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
    J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of a new in vitro bleeding time device on surgical patients.
    Tsujinaka T; Itoh T; Uemura Y; Sakon M; Kambayashi J; Mori T
    Jpn J Surg; 1988 Jul; 18(4):430-7. PubMed ID: 2845175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between the LMWH reviparin and aspirin in healthy volunteers.
    Klinkhardt U; Breddin HK; Esslinger HU; Haas S; Kalatzis A; Harder S
    Br J Clin Pharmacol; 2000 Apr; 49(4):337-41. PubMed ID: 10759689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin.
    Dallob A; Luo WL; Luk JM; Ratcliffe L; Johnson-Levonas AO; Schwartz JI; Dishy V; Kraft WK; De Hoon JN; Van Hecken A; De Lepeleire I; Radziszewski W; Wagner JA; Lai E
    Platelets; 2011; 22(7):495-503. PubMed ID: 21526889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the effects of D-003, a new antiplatelet and lipid-lowering compound, in healthy volunteers. A phase I clinical study.
    Castaño G; Más R; Fernández L; López E; Gutiérrez JA; Illnait J; Fernández JC; Gámez R; Alvarez E
    Drugs R D; 2002; 3(5):337-48. PubMed ID: 12455155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    Serebruany VL; Malinin AI; Sane DC
    Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin use and post-operative bleeding from dental extractions.
    Brennan MT; Valerin MA; Noll JL; Napeñas JJ; Kent ML; Fox PC; Sasser HC; Lockhart PB
    J Dent Res; 2008 Aug; 87(8):740-4. PubMed ID: 18650545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.